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Although often considered only a medical 
problem, antimicrobial resistance is an evo-
lutionary challenge accelerated by social, 
cultural and economic factors that lead to 
the misuse, overuse and abuse of life-saving 
antimicrobial medicines. The antimicrobial 
resistance challenge is compounded by in-
adequate attention to disease prevention 
and response, global circulation of people 
and products, differences in industry and 
market regulations across countries, and a 
fragile pipeline of new antibiotics and their 
alternatives. While the discovery of new 
antimicrobials will provide temporary solu-
tions, sustainable success requires rigorous 
social science research that explores the 
drivers of antimicrobial resistance. These 
solutions should promote balance between 
equitable access to, conservation of, and 
innovation for antimicrobials, adapted to 
local conditions across the globe.1–3
Effective actions against antimicro-
bial resistance will need to be informed 
by insights and evidence from the social 
sciences, encompassing a broad variety 
of disciplines. From our perspective, 
current engagement with the full range 
of social sciences is inadequate; greater 
collaboration within and between social 
science disciplines must be prioritized. 
Only then can we generate sufficient cross-
sectional knowledge to overcome obstacles 
to addressing antimicrobial resistance, 
including inequitable access to effective 
antimicrobials, inadequate sanitation and 
hygiene infrastructure, disincentives for 
appropriate use of existing antimicrobials, 
and insufficient incentive for innovation 
in developing new antimicrobials.4 Col-
laboration among social scientists from 
various disciplines is also needed to help 
anticipate unintended consequences of 
action, such as inadvertently driving the 
use of suboptimal antibiotics by raising 
concerns about resistance.5,6
In the past 15 years, social science re-
search has generated substantial knowledge 
about the systemic causes of antimicrobial 
resistance and has identified feasible inter-
ventions. After the World Health Assembly 
adopted the Global action plan on antimi-
crobial resistance in 2015, more than 120 
countries developed national action plans. 
Despite this progress, challenges remain, 
such as how to scale-up access to anti-
microbials without scaling-up resistance, 
identifying the clinical practices that can 
reduce antimicrobial use without risking 
lives, and how to de-link the price of anti-
microbials from the cost of their develop-
ment.7–10 Existing global efforts may be too 
slow to counter antimicrobial resistance, 
given the lack of political commitment, the 
challenge of addressing transboundary col-
lective action problems, and the difficulty 
in balancing antimicrobial resistance with 
other global threats.11 A range of social 
science disciplines can provide essential 
analytic tools for developing solutions for 
such global challenges.
To encourage collaboration and to 
address this challenge, we have created the 
International Network for Antimicrobial 
Resistance Social Science (INAMRSS).12 
The network is an open consortium of 
social science researchers focused on ad-
dressing the global challenge of antimicro-
bial resistance. We believe antimicrobial 
resistance is only surmountable through 
efforts that consider social, political and 
economic factors. We intend to champion 
social science as part of a broadly defined 
One Health perspective to inform global 
initiatives. INAMRSS is a member of the 
Global AMR R&D Hub stakeholder group, 
which has built a system to track antimicro-
bial resistance research investment, but has 
not yet started monitoring relevant social 
science research funding. We endorse 
the recommendation of the United Na-
tions Interagency Coordination Group on 
Antimicrobial Resistance for creating an 
Independent Panel on Evidence for Action 
against such resistance, with appropriate 
expertise across disciplines including the 
social sciences, and with a focus on the ways 
that humans are driving this problem and 
can contribute to solutions.
As initial steps, INAMRSS strongly 
recommends several coordinated initia-
tives to better identify and implement 
valuable social science insights to support 
and inform much needed action against 
antimicrobial resistance. These initiatives 
include (i) tracking inputs and outputs of 
social science research, including map-
ping current research spending, research 
publications and identifying key gaps; 
(ii) including social scientists in antimi-
crobial resistance research teams, panels, 
and proposals; (iii) exploring social sci-
ence interventions to address antimicro-
bial resistance at individual, population 
and systemic levels; (iv) identifying key 
requirements for infrastructure support 
and international coordination, such as 
the Independent Panel on Evidence for Ac-
tion Against Antimicrobial Resistance and 
the Global AMR R&D Hub; and (v) using 
the data generated above to appropriately 
fund social science research. Only when 
we consider the multidisciplinary aspects 
of the challenge together, will we prevail 
in addressing antimicrobial resistance. ■
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